Citadel Advisors - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$112,992
+10.7%
117,700
-13.5%
0.00%
Q1 2023$102,075
-44.0%
136,100
-72.5%
0.00%
Q4 2022$182,404
+68.9%
494,992
+95.9%
0.00%
Q3 2022$108,000
-84.1%
252,700
-71.0%
0.00%
Q2 2022$679,000
+309.0%
870,828
+573.9%
0.00%
Q1 2022$166,000
-78.8%
129,213
-79.0%
0.00%
Q4 2021$782,000
+34.4%
616,019
+130.4%
0.00%
Q3 2021$582,000
-57.0%
267,335
-26.0%
0.00%
Q2 2021$1,355,000
+75.3%
361,174
+52.4%
0.00%
Q1 2021$773,000
-31.5%
236,986
-28.4%
0.00%
Q4 2020$1,128,000
+154.1%
330,959
+204.2%
0.00%
Q3 2020$444,000
-71.1%
108,800
-76.0%
0.00%
Q2 2020$1,536,000
+353.1%
454,215
+212.1%
0.00%
Q1 2020$339,000
-73.1%
145,549
-58.0%
0.00%
Q4 2019$1,260,000
+43.8%
346,312
+228.2%
0.00%
Q3 2019$876,000
-87.8%
105,529
-87.3%
0.00%
-100.0%
Q2 2019$7,170,000
+73.2%
832,712
+115.0%
0.00%
+50.0%
Q1 2019$4,140,000
+96.8%
387,229
+61.0%
0.00%
+100.0%
Q4 2018$2,104,000
-93.0%
240,494
-86.5%
0.00%
-92.9%
Q3 2018$29,981,000
+5.6%
1,784,631
+31.7%
0.01%0.0%
Q2 2018$28,398,000
+1192.6%
1,354,864
+891.8%
0.01%
Q1 2018$2,197,000
+60.0%
136,601
+88.4%
0.00%
Q4 2017$1,373,000
-14.7%
72,500
-36.6%
0.00%
-100.0%
Q3 2017$1,610,000
+88.1%
114,414
-0.4%
0.00%0.0%
Q2 2017$856,000
-64.9%
114,914
-69.4%
0.00%
-50.0%
Q1 2017$2,439,000
-11.1%
375,249
-39.4%
0.00%
-33.3%
Q4 2016$2,743,000
+198.5%
619,082
+214.9%
0.00%
+200.0%
Q3 2016$919,000
+27.6%
196,614
+79.5%
0.00%0.0%
Q2 2016$720,000
+1163.2%
109,525
+1052.3%
0.00%
Q4 2015$57,000
-74.0%
9,505
-74.1%
0.00%
Q3 2015$219,000
-96.6%
36,718
-96.6%
0.00%
-100.0%
Q1 2015$6,494,000
+908.4%
1,069,827
+1051.0%
0.01%
+500.0%
Q4 2014$644,000
-76.2%
92,944
-72.0%
0.00%
-66.7%
Q3 2014$2,702,000
+466.5%
331,931
+465.2%
0.00%
+200.0%
Q2 2014$477,000
-21.7%
58,729
-24.4%
0.00%0.0%
Q1 2014$609,000
+80.7%
77,703
+103.9%
0.00%
Q4 2013$337,000
+49.1%
38,116
+41.6%
0.00%
Q3 2013$226,000
-8.1%
26,919
-18.4%
0.00%
Q2 2013$246,00032,9760.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders